ATE161041T1 - Verfahren zur hcv-züchtung in zell-linien aus b- oder t-lymphozyten - Google Patents

Verfahren zur hcv-züchtung in zell-linien aus b- oder t-lymphozyten

Info

Publication number: ATE161041T1
Authority: AT; Austria
Prior art keywords: hcv; lymphocytes; cultivation; cell lines; directed
Prior art date: 1989-08-25

Application number

AT90309120T

Other languages

English (en)

Inventor

Amy J Weiner

Kathelyn S Steimer

Michael Houghton

Original Assignee

Chiron Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-08-25

Filing date

1990-08-21

Publication date

1997-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23576300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE161041(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-08-21 Application filed by Chiron Corp filed Critical Chiron Corp

1997-12-15 Application granted granted Critical

1997-12-15 Publication of ATE161041T1 publication Critical patent/ATE161041T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Gastroenterology & Hepatology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Immunology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
Details Of Audible-Bandwidth Transducers (AREA)
Telephone Function (AREA)

AT90309120T 1989-08-25 1990-08-21 Verfahren zur hcv-züchtung in zell-linien aus b- oder t-lymphozyten ATE161041T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US39866789A	1989-08-25	1989-08-25

Publications (1)

Publication Number	Publication Date
ATE161041T1 true ATE161041T1 (de)	1997-12-15

Family

ID=23576300

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90309120T ATE161041T1 (de)	1989-08-25	1990-08-21	Verfahren zur hcv-züchtung in zell-linien aus b- oder t-lymphozyten

Country Status (12)

Country	Link
EP (1)	EP0414475B1 (de)
JP (3)	JPH05502156A (de)
AT (1)	ATE161041T1 (de)
AU (1)	AU655156B2 (de)
CA (1)	CA2064705C (de)
DE (1)	DE69031791T2 (de)
DK (1)	DK0414475T3 (de)
ES (1)	ES2110411T3 (de)
GR (1)	GR3026114T3 (de)
IE (1)	IE903097A1 (de)
PT (1)	PT95093B (de)
WO (1)	WO1991002820A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7166287B1 (en)	1989-12-18	2007-01-23	Glaxo Wellcome Inc.	Viral agent
AR243239A1 (es)	1989-12-18	1993-07-30	Wellcome Found	Procedimiento para preparar polipeptido.
CA2079677A1 (en) *	1990-04-03	1991-10-04	Kenneth H. Burk	Purified hcv and hcv proteins and peptides
IE911130A1 (en) *	1990-04-04	1991-10-09	Protos	Hepatitis c protease inhibitors
ES2152922T3 (es) *	1990-04-06	2001-02-16	Genelabs Tech Inc	Epitopos del virus de la hepatitis c.
US5747339A (en)	1990-06-25	1998-05-05	Research Foundation For Microbial Diseases Of Osaka	Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
US5574132A (en) *	1991-04-05	1996-11-12	Biochem Immunosystems Inc.	Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
CA2065690A1 (en) *	1991-04-10	1992-10-11	Hiroaki Okamoto	Non-a, non-b hepatitis related antigens, detection systems, polynucleotides and polypeptides
US5428145A (en) *	1991-08-09	1995-06-27	Immuno Japan, Inc.	Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
AU671967B2 (en) *	1991-11-21	1996-09-19	Common Services Agency	Hepatitis-C virus testing
US5552310A (en) *	1992-06-12	1996-09-03	Hiroshi Yoshikura	Replication of hepatitis C virus genome and identification of virus having high infectivity
AU6943994A (en) *	1993-05-04	1994-11-21	United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Hepatitis c virus cell propagation and related methods
US5840565A (en)	1995-08-22	1998-11-24	The Regents Of The University Of California	Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US6127116A (en)	1995-08-29	2000-10-03	Washington University	Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5851758A (en) *	1995-10-25	1998-12-22	Childrens Research Institute	Cytopathic replication of hepatitis C virus in a new cell line
US6242187B1 (en)	1996-01-29	2001-06-05	Virologic, Inc.	Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
AP9801360A0 (en) *	1996-01-29	1998-12-31	Virologic Incorporated	Compositions and methods ofr determining anti-viral drug susceptibility and resistance and anti-viral drug screening.
DE69739268D1 (de)	1996-11-08	2009-04-02	Us Gov Health & Human Serv	Herstellung und reinigung von hepatitis c virus-ähnlichen partikeln
US7338759B1 (en)	1997-03-04	2008-03-04	Washington University	HCV variants
US7049428B1 (en)	1998-03-04	2006-05-23	Washington University	HCV variants
AT407256B (de) *	1998-06-24	2001-02-26	Immuno Ag	Hepatitis c-virus positive endometriale zelllinie
US6680059B2 (en)	2000-08-29	2004-01-20	Tripep Ab	Vaccines containing ribavirin and methods of use thereof
US6858590B2 (en)	2000-08-17	2005-02-22	Tripep Ab	Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en)	2000-08-17	2006-04-04	Tripep Ab	Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
EP1311289B1 (de)	2000-08-17	2007-10-17	Tripep Ab	Ribavirin-enthaltende vakzine
EP1888751A2 (de)	2005-05-25	2008-02-20	Tripep Ab	Nichtstrukturelles ns3/4a-fusionsgen des hepatitis-c-virus
US20090214593A1 (en)	2007-08-16	2009-08-27	Tripep Ab	Immunogen platform
EP2185195A2 (de)	2007-08-16	2010-05-19	Tripep Ab	Immunogen-plattform
GB201119011D0 (en) *	2011-11-03	2011-12-14	Queen Mary Innovation Ltd	Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4464474A (en) *	1980-07-09	1984-08-07	Connaught Laboratories Limited	Non-A, non-B hepatitis assay and vaccine
EP0071640B1 (de) *	1981-02-11	1986-06-04	Connaught Laboratories Incorporated	Nicht-a, nicht-b hepatitisvirus
EP0261233A4 (de) *	1986-04-01	1988-08-29	Genelabs Inc	Immortalisierte virus-spezifische gewebezellen.
ES2012739T5 (es) *	1987-11-18	2001-12-01	Chiron Corp	Diagnosticos para nanbv.

1990
- 1990-08-21 DK DK90309120.5T patent/DK0414475T3/da active
- 1990-08-21 EP EP90309120A patent/EP0414475B1/de not_active Expired - Lifetime
- 1990-08-21 ES ES90309120T patent/ES2110411T3/es not_active Expired - Lifetime
- 1990-08-21 AT AT90309120T patent/ATE161041T1/de not_active IP Right Cessation
- 1990-08-21 DE DE69031791T patent/DE69031791T2/de not_active Expired - Lifetime
- 1990-08-22 WO PCT/US1990/004766 patent/WO1991002820A1/en active Application Filing
- 1990-08-22 AU AU63449/90A patent/AU655156B2/en not_active Expired
- 1990-08-22 CA CA002064705A patent/CA2064705C/en not_active Expired - Lifetime
- 1990-08-22 JP JP2512531A patent/JPH05502156A/ja not_active Withdrawn
- 1990-08-24 PT PT95093A patent/PT95093B/pt not_active IP Right Cessation
- 1990-08-24 IE IE309790A patent/IE903097A1/en not_active IP Right Cessation
1998
- 1998-02-12 GR GR980400286T patent/GR3026114T3/el unknown
2001
- 2001-03-15 JP JP2001075114A patent/JP2001314192A/ja not_active Withdrawn
2003
- 2003-06-24 JP JP2003180211A patent/JP2004049235A/ja active Pending

Also Published As

Publication number	Publication date
DK0414475T3 (da)	1998-02-09
PT95093A (pt)	1991-05-22
DE69031791D1 (de)	1998-01-22
JPH05502156A (ja)	1993-04-22
CA2064705A1 (en)	1991-02-26
EP0414475B1 (de)	1997-12-10
GR3026114T3 (en)	1998-05-29
AU6344990A (en)	1991-04-03
WO1991002820A1 (en)	1991-03-07
EP0414475A1 (de)	1991-02-27
JP2004049235A (ja)	2004-02-19
IE903097A1 (en)	1991-02-27
AU655156B2 (en)	1994-12-08
JP2001314192A (ja)	2001-11-13
DE69031791T2 (de)	1998-04-02
PT95093B (pt)	1997-11-28
ES2110411T3 (es)	1998-02-16
CA2064705C (en)	1999-04-06

Similar Documents

Publication	Publication Date	Title
ATE161041T1 (de)	1997-12-15	Verfahren zur hcv-züchtung in zell-linien aus b- oder t-lymphozyten
YU45871B (sh)	1992-09-07	Polipeptid sa humanim imunointerferonskim (ifn-gama) svojstvima
DE69132098D1 (de)	2000-05-11	Verfahren zur amplifikation von nukleinsäuren
ATE301707T1 (de)	2005-08-15	Aus einer mit einem stamm von multiple-sklerosis- virus infizierten zellinie hergestelltes biologisches virusmaterial
ATE2442T1 (de)	1983-03-15	Verfahren zur herstellung von interferon und dabei verwendete kulturmediumzusammensetzung.
ATE8409T1 (de)	1984-07-15	Verfahren zum vermehren menschlicher hepatitis-a viren in einer zellkultur in vitro.
ATE530657T1 (de)	2011-11-15	Verfahren zur herstellung von zellinien mit latentem immunschwächevirus
DE3484090D1 (de)	1991-03-14	Verfahren zur herstellung von thermostabilen alpha-amylasen durch zuechtung von mikroorganismen bei erhoehten temperaturen.
ATA292889A (de)	1991-03-15	Verfahren zur herstellung von fsme-virus-antigen
DE69111406D1 (de)	1995-08-24	DNA-Isolierungsverfahren.
EP0278487A3 (de)	1990-01-17	Verfahren zur Inaktivierung hüllhaltiger Viren in mittels einer Zelle in vitro hergestellten Protein-Präparationen
DE69322227D1 (de)	1999-01-07	Verfahren zur herstellung von lebenden zellkulturen, die durch einen multiple sklerose assoziierten virus infiziert sind
DE3882154D1 (de)	1993-08-12	Verfahren zur herstellung des pres 1/s2/s-hepatitis-b-antigens aus hefe.
ATE13910T1 (de)	1985-07-15	Verfahren zur zuechtung von humanen fibroblasten und fibroblastenartigen zellen.
DE3884777D1 (de)	1993-11-11	Verfahren zur Herstellung von Pregneno-Oxazolinen.
DE69331696D1 (de)	2002-04-18	Stabilisierte kultur von zellularaggregaten und verfahren zur entwicklung von embryos aus proembryogenen stämmen für die regeneration von weinreben
DK439086D0 (da)	1986-09-12	Fremgangsmaader til anvendelse af cellelinier, der mangler humane klasseii histokompatibilitetsantigener
ATE33842T1 (de)	1988-05-15	Immuninterferon und verfahren zu seiner reinigung.
ATE51026T1 (de)	1990-03-15	Hybridzellen, die ein hepatitis-b-virus-antigen produzieren, aus hepatocyten und errichteten affenzellen, verfahren zur herstellung dieser hybridzellen und verwendung derselben zur herstellung der obenerwaehnten antigens.
DE69012903D1 (de)	1994-11-03	Verfahren zur herstellung und reinigung von hepatitis b-impfstoff.
ATE30244T1 (de)	1987-10-15	Verfahren und vorrichtung zur kultivierung von mikroorganismen.
ATE49777T1 (de)	1990-02-15	Verfahren zur zuechtung von hepatozyten und cozuechtung von hepatozyten und von behandelten epithelien leberzellen.
DE69311552D1 (de)	1997-07-17	Verfahren zur vermehrung von infektionsagenzien in "in-vitro"-diagnostik mit mykoplasma enthaltenden zellenkulturen
DD138327A1 (de)	1979-10-24	Verfahren zur kultivierung von mikroorganismen und deren abtrennung aus dem kulturmedium
AT380696B (de)	1986-06-25	Verfahren zur effektivierung der erzeugung von proteinen in bakterien der gattung bacillus

Legal Events

Date	Code	Title	Description
1998-06-15	UEP	Publication of translation of european patent specification
2010-11-15	EELA	Cancelled due to lapse of time